- Home
- GTEC vs ELEV Comparison
GTEC vs ELEV Comparison
Compare GTEC & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTEC
- ELEV
- Stock Information
- Founded
- GTEC 2006
- ELEV 2019
- Country
- GTEC United States
- ELEV United States
- Employees
- GTEC N/A
- ELEV N/A
- Industry
- GTEC Industrial Machinery/Components
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- GTEC Industrials
- ELEV Health Care
- Exchange
- GTEC Nasdaq
- ELEV Nasdaq
- Market Cap
- GTEC 33.0M
- ELEV 37.6M
- IPO Year
- GTEC N/A
- ELEV 2021
- Fundamental
- Price
- GTEC $2.01
- ELEV $0.63
- Analyst Decision
- GTEC
- ELEV Strong Buy
- Analyst Count
- GTEC 0
- ELEV 5
- Target Price
- GTEC N/A
- ELEV $7.20
- AVG Volume (30 Days)
- GTEC 79.1K
- ELEV 720.2K
- Earning Date
- GTEC 11-14-2024
- ELEV 11-06-2024
- Dividend Yield
- GTEC N/A
- ELEV N/A
- EPS Growth
- GTEC N/A
- ELEV N/A
- EPS
- GTEC N/A
- ELEV N/A
- Revenue
- GTEC $87,352,614.00
- ELEV N/A
- Revenue This Year
- GTEC N/A
- ELEV N/A
- Revenue Next Year
- GTEC $1.70
- ELEV N/A
- P/E Ratio
- GTEC N/A
- ELEV N/A
- Revenue Growth
- GTEC 0.76
- ELEV N/A
- 52 Week Low
- GTEC $1.36
- ELEV $0.44
- 52 Week High
- GTEC $3.84
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- GTEC 38.07
- ELEV 49.52
- Support Level
- GTEC $2.01
- ELEV $0.61
- Resistance Level
- GTEC $2.15
- ELEV $0.70
- Average True Range (ATR)
- GTEC 0.12
- ELEV 0.08
- MACD
- GTEC -0.00
- ELEV 0.00
- Stochastic Oscillator
- GTEC 27.42
- ELEV 25.10
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of innovative and quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.